Aziyo Biologics Inc reports results for the quarter ended in December - Earnings Summary

Elutia

22/03/2023 21:01

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 38 cents​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 69 cents per share.
    * Revenue rose 16.6% to $12.67 million from a year ago;
analysts
expected $12.55 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 38 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aziyo Biologics Inc shares had fallen by 71.3% this
quarter.
    * The company reported a quarterly loss of $5.44 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.69          -0.38          Beat
 Sep. 30 2022      -0.66          -0.73          Missed
 Jun. 30 2022      -0.56          -0.69          Missed
 Mar. 31 2022      -0.62          -0.60          Beat